Specify a stock or a cryptocurrency in the search bar to get a summary
Cognetivity Neurosciences Ltd
CGNCognetivity Neurosciences Ltd. operates as a technology company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada. Address: 1055 West Hastings Street, Vancouver, BC, Canada, V6E 2E9
Analytics
WallStreet Target Price
1.04 CADP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures CGN
Dividend Analytics CGN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CGN
Stock Valuation CGN
Financials CGN
Results | 2019 | Dynamics |